Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Musunuru

Showing results (1-10 of 218) with videos related to

Pageof 22
Sort By:
Cardiovascular Research|April 7, 2022
CRISPR and cardiovascular diseasesKiran Musunuru
Circulation. Cardiovascular Genetics|August 18, 2011
Lack of association of KIF6 genotype with vascular disease and statin responseKiran Musunuru
Nature Biomedical Engineering|January 16, 2020
Correcting tyrosinaemia via a point mutationKiran Musunuru
Annual Review of Medicine|November 25, 2020
Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 InhibitionKiran Musunuru
Advances in Experimental Medicine and Biology|December 1, 2022
An Overview of Genome Editing in Cardiovascular and Metabolic DiseasesKiran Musunuru
Circulation. Cardiovascular Genetics|August 17, 2012
Induction of cardiomyocytes from cardiac fibroblastsKiran Musunuru
The New England Journal of Medicine|October 24, 2024
A Milestone for Gene-Editing TherapiesKiran Musunuru
Lipids|June 5, 2010
Atherogenic dyslipidemia: cardiovascular risk and dietary interventionKiran Musunuru
Journal of the American College of Cardiology|December 2, 2017
Genome Editing: The Recent History and Perspective in Cardiovascular DiseasesKiran Musunuru
JAMA Cardiology|June 15, 2017
The Hope and Hype of CRISPR-Cas9 Genome Editing: A ReviewKiran Musunuru
Pageof 22

Showing results (1-10 of 218) with videos related to

Sort By:
Pageof 22
Cardiovascular Research|April 7, 2022
CRISPR and cardiovascular diseasesKiran Musunuru
Circulation. Cardiovascular Genetics|August 18, 2011
Lack of association of KIF6 genotype with vascular disease and statin responseKiran Musunuru
Nature Biomedical Engineering|January 16, 2020
Correcting tyrosinaemia via a point mutationKiran Musunuru
Annual Review of Medicine|November 25, 2020
Treating Coronary Artery Disease: Beyond Statins, Ezetimibe, and PCSK9 InhibitionKiran Musunuru
Advances in Experimental Medicine and Biology|December 1, 2022
An Overview of Genome Editing in Cardiovascular and Metabolic DiseasesKiran Musunuru
Circulation. Cardiovascular Genetics|August 17, 2012
Induction of cardiomyocytes from cardiac fibroblastsKiran Musunuru
The New England Journal of Medicine|October 24, 2024
A Milestone for Gene-Editing TherapiesKiran Musunuru
Lipids|June 5, 2010
Atherogenic dyslipidemia: cardiovascular risk and dietary interventionKiran Musunuru
Journal of the American College of Cardiology|December 2, 2017
Genome Editing: The Recent History and Perspective in Cardiovascular DiseasesKiran Musunuru
JAMA Cardiology|June 15, 2017
The Hope and Hype of CRISPR-Cas9 Genome Editing: A ReviewKiran Musunuru
Pageof 22